ecrin-mdr-crcClinical2008AdenocarcinomaAdenocarcinoma of the RectumColorectal cancer metastaticColorectal NeoplasmsMetastatic colorectal cancerAdvanced Colorectal CancerColorectal cancer recurrentColorectal cancer stage IVAdenocarcinoma of the ColonAdenocarcinomaMetastatic Colorectal CancerColorectal Cancer Stage IvAdenocarcinoma Of The RectumColorectal Cancer RecurrentColorectal NeoplasmsColorectal Cancer MetastaticAdenocarcinoma Of The ColonAdvanced Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2057654RomaniaCzechiaUnited StatesPortugalRussiaSpainGreeceNew ZealandCanadaSouth KoreaBelgiumBrazilPolandAustralia10Folic AcidOxaliplatinABT-869LevoleucovorinLeucovorinFluorouracilBevacizumabECRIN MDRCompletedfalsePhase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerTo determine the effect of ABT-869 plus mFOLFOX6 compared to bevacizumab plus mFOLFOX6 on disease progression in advanced colorectal cancer.2008-10-152057654NCT007078892007-007081-38